ZBED3-AS1

Across TCGA pan-cancer cohorts, ZBED3-AS1 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated ZBED3-AS1 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher ZBED3-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated ZBED3-AS1 expression acts as an unfavorable survival marker, although some lineages such as KIRP and PAAD show a favorable association.

KIRP, UCEC, and PAAD are the cancer types where ZBED3-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Median	II,III,IV	0.786	0.376	.004	49	view →
UCEC	DFS	Quartile	All	0.794	0.910	.002	40	view →
PAAD	OS	Median	All	0.508	0.293	.001	31	view →
BRCA	OS	Tertile	III,IV	0.897	0.742	.003	31	view →
READ	DFS	Tertile	All	0.841	0.291	.009	30	view →
KICH	DFS	Tertile	All	0.799	1.000	.021	26	view →
THYM	OS	Tertile	All	0.616	1.000	.001	25	view →
DLBC	DFS	Median	All	0.858	0.358	.010	19	view →
COAD	OS	Tertile	All	0.447	0.753	.009	14	view →
UVM	DFS	Tertile	III,IV	0.099	1.000	.002	12	view →
UCS	DFS	Tertile	IV	0.978	0.668	.036	12	view →
SKCM	OS	Quartile	All	0.260	0.488	.004	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

ZBED3-AS1–KIRP (OS)

Open the KIRP breakdown →